Neu A M, Warady B A, Furth S L, Lederman H M, Fivush B A
Division of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Adv Perit Dial. 1997;13:297-9.
To determine whether infants who receive routine childhood immunizations while on chronic peritoneal dialysis (CPD) develop protective antibody levels/titers, we measured antibody levels/titers in infants vaccinated with diphtheria/tetanus/pertussis (DTP) and measles/mumps/rubella (MMR) while on CPD. Eight CPD patients (median age 19 months, range 9-39 months) had measurement of antibody to diphtheria and tetanus toxoids. Seven of the 8 (88%) had protective levels of IgG antibody to both toxoids. The single patient who did not have protective antibody to either diphtheria or tetanus had a low total serum IgG. However, 3 other patients who had low IgG had protective antibody levels. Serial measurements of antibody to tetanus and diphtheria were obtained in 3 of the 8 patients. All maintained protective levels to both diphtheria and tetanus toxoids for as long as 24 months postvaccination. Antibody to rubella was also measured in 5 CPD patients (median 29 months, range 19-39 months), and all had protective antibody titers despite the fact that 3 had low total serum levels. In conclusion, most but not all infants immunized while on CPD have protective antibody levels/titers to diphtherial, tetanus, rubella. Alteration of the routine schedule for immunizations does not appear to be necessary. However, periodic measurements of antibody may be indicated, particularly to live vial vaccines, prior to transplantation.
为了确定接受慢性腹膜透析(CPD)的婴儿在进行常规儿童免疫接种后是否能产生保护性抗体水平/滴度,我们测量了接受白喉/破伤风/百日咳(DTP)和麻疹/腮腺炎/风疹(MMR)疫苗接种的CPD婴儿的抗体水平/滴度。8例CPD患者(中位年龄19个月,范围9 - 39个月)检测了对白喉和破伤风类毒素的抗体。8例中的7例(88%)对两种类毒素均具有保护性IgG抗体水平。对两种类毒素均无保护性抗体的唯一患者血清总IgG水平较低。然而,其他3例IgG水平较低的患者却具有保护性抗体水平。8例患者中的3例进行了破伤风和白喉抗体的系列测量。所有患者在接种疫苗后长达24个月内对白喉和破伤风类毒素均维持保护性水平。还对5例CPD患者(中位年龄29个月,范围19 - 39个月)检测了风疹抗体,尽管其中3例血清总水平较低,但所有患者均具有保护性抗体滴度。总之,大多数(但并非全部)接受CPD治疗时免疫接种的婴儿对白喉、破伤风、风疹具有保护性抗体水平/滴度。似乎没有必要改变常规免疫接种计划。然而,在移植前可能需要定期检测抗体,尤其是对活病毒疫苗。